Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...
U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...
"People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of ...
For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...
Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker ...
Funding from the Governments of Canada and Alberta will contribute to the new R&D center and GMP manufacturing facility in ...
Answering media questions on whether Apple Inc should return to the US, the president said “Apple has been treated very badly ...
While weight-loss drugs like Zepbound (LLY) and Wegovy (NVO) offer significant health benefits, their high costs make them ...
New Vision on MSN4d
Trump blasts Ireland on trade during traditional visitWASHINGTON: It was perhaps not the welcome Irish Prime Minister Micheal Martin had hoped for on an annual US trip to mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback